FCENX
Price
$15.13
Change
-$0.07 (-0.46%)
Updated
Jul 31 closing price
Net Assets
366.51M
VTMNX
Price
$22.79
Change
-$0.08 (-0.35%)
Updated
Jul 31 closing price
Net Assets
316.31B
Interact to see
Advertisement

FCENX vs VTMNX

FCENX vs VTMNX Comparison Chart in %
View a ticker or compare two or three
VS
FCENX vs. VTMNX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCENX is a Hold and VTMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 316B vs. FCENX (367M). VTMNX pays higher dividends than FCENX: VTMNX (2.56) vs FCENX (2.07). FCENX was incepted earlier than VTMNX: FCENX (7 years) vs VTMNX (26 years). FCENX (0.05) is less costly to investors than VTMNX (0.03). FCENX is a more actively managed with annual turnover of: 65.93 vs. VTMNX (4.00). FCENX has a lower initial minimum investment than VTMNX: FCENX (0) vs VTMNX (5000000). VTMNX annual gain was more profitable for investors over the last year : 27.12 vs. FCENX (14.87). VTMNX return over 5 years is better than : 40.66 vs. FCENX (34.19).
FCENXVTMNXFCENX / VTMNX
Total Expense Ratio0.000.03-
Annual Report Gross Expense Ratio0.050.03167%
Fund Existence7 years26 years-
Gain YTD12.89713.70694%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets367M316B0%
Annual Yield % from dividends2.072.5681%
Returns for 1 year14.8727.1255%
Returns for 3 years49.0853.0493%
Returns for 5 years34.1940.6684%
Returns for 10 yearsN/A105.34-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLX58.550.23
+0.39%
Bladex Inc
XLO9.110.03
+0.33%
Xilio Therapeutics Inc.
DMIIU10.15N/A
N/A
Drugs Made In America Acquisition II Corp
CRL232.51-2.11
-0.90%
Charles River Laboratories International
EPRX6.40-0.15
-2.29%
Eupraxia Pharmaceuticals